COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

CARES Lumbar Artificial Disc Registry

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02139527
Recruitment Status : Terminated (Low enrollment and follow-up data on enrolled patients.)
First Posted : May 15, 2014
Last Update Posted : May 15, 2014
Information provided by (Responsible Party):
DePuy Spine

Brief Summary:
The purpose of the registry is to assess outcomes following treatment with lumbar total disc replacement (TDR) in patients outside the clinical trial setting.

Condition or disease Intervention/treatment
Lumbar Degenerative Disc Disease Device: Total Disc Replacement

Detailed Description:
The purpose of this study is to capture outcomes associated with use of total disc replacement (TDR) in patients treated with either the CHARITE™ Artificial Disc or the PRODISC®-L Total Disc Replacement may be included in the registry.

Layout table for study information
Study Type : Observational [Patient Registry]
Actual Enrollment : 120 participants
Observational Model: Case-Only
Time Perspective: Prospective
Target Follow-Up Duration: 5 Years
Official Title: The Centers for Arthroplasty Research and Education in Spine (CARES) Lumbar Artificial Disc Registry Protocol
Study Start Date : May 2007
Actual Primary Completion Date : August 2009
Actual Study Completion Date : August 2009

Resource links provided by the National Library of Medicine

Intervention Details:
  • Device: Total Disc Replacement
    Other Names:
    • CHARITE™ Artificial Disc
    • PRODISC®-L Total Disc Replacement

Primary Outcome Measures :
  1. Change in Oswestry Disability Index (ODI) Score [ Time Frame: 3, 6, 12, 24, 36, 48, and 60 months post operative ]
    The ODI assesses several domains of function affected by low back pain. A change of 15 points from baseline is considered a clinical meaningful difference for the individual. The change from pre operative baseline to each follow-up assessment will be calculated.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients that undergo lumbar total disc replacement (TDR); this includes patients treated with either the CHARITE disc or the ProDisc-L disc

Key Inclusion Criteria:

  • Treated with the lumbar TDR.
  • Signed IRB approved consent document.

Key Exclusion Criteria:

  • None known.
Additional Information:

Layout table for additonal information
Responsible Party: DePuy Spine Identifier: NCT02139527    
Other Study ID Numbers: 06-CAD-01
First Posted: May 15, 2014    Key Record Dates
Last Update Posted: May 15, 2014
Last Verified: May 2014
Keywords provided by DePuy Spine:
Additional relevant MeSH terms:
Layout table for MeSH terms
Intervertebral Disc Degeneration
Spinal Diseases
Bone Diseases
Musculoskeletal Diseases